BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2022 7:25:42 AM | Browse: 548 | Download: 1346
 |
Received |
|
2022-02-23 02:07 |
 |
Peer-Review Started |
|
2022-02-23 02:08 |
 |
First Decision by Editorial Office Director |
|
2022-04-18 07:10 |
 |
Return for Revision |
|
2022-04-18 07:10 |
 |
Revised |
|
2022-04-19 07:02 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-06-29 03:16 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-07-06 19:29 |
 |
Articles in Press |
|
2022-07-06 19:29 |
 |
Edit the Manuscript by Language Editor |
|
2022-06-22 02:03 |
 |
Typeset the Manuscript |
|
2022-08-09 12:49 |
 |
Publish the Manuscript Online |
|
2022-08-18 07:25 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zheng Liu, Mo-Lin Zhang, Xin-Ru Tang, Xiao-Qing Li, Jing Wang and Li-Liang Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82070285 |
| National Natural Science Foundation of China |
81701861 |
|
| Corresponding Author |
Li-Liang Li, MD, PhD, Associate Professor, Teacher, Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, No. 131 Dongan Road, Shanghai 200032, China. liliangli11@fudan.edu.cn |
| Key Words |
Antipsychotics; Cardiotoxicity; Combined medication; Adjunct therapy |
| Core Tip |
The newer antipsychotics have been reported to have fewer side effects and better performance in efficacy in short-term studies. Still, a dilemma lies between the benefit of ameliorating psychotic symptoms and severe side effects especially life-threatening cardiotoxicity in antipsychotic medications in clinical practice. The combination of antipsychotics with other therapeutic agents providing cardioprotection, such as β-blockers, cannabinoid 1 receptor antagonists, cannabinoid 2 receptor agonists, spliceosome inhibitors, angiotensin-converting enzyme inhibitors and n-3 polyunsaturated fatty acids, may represent a promising strategy and sweet pledge. |
| Publish Date |
2022-08-18 07:25 |
| Citation |
Liu Z, Zhang ML, Tang XR, Li XQ, Wang J, Li LL. Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy? World J Psychiatry 2022; 12(8): 1108-1111
|
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i8/1108.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i8.1108 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.